Medtronic’s Stealth AXiS FDA Win Meets Mixed Share Performance

Medtronic (NYSE:MDT) received U.S. FDA clearance for its Stealth AXiS surgical system for cranial and ENT procedures. The platform combines AI enabled planning, navigation, and robotics for use across ...
The American Journal of Managed Care

Ultrasound Method Linked With Improved Survival in Patients With CRC Liver Metastases

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...
Business Wire

GE HealthCare Announces Availability of Next-Generation bkActiv for Guiding Urology, Colorectal and Pelvic Floor Surgeries

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures. The flagship ...
Renal & Urology News

Ultrasound, 3D Printing Aid Sacral Neuromodulation for Neurogenic Bladder

Fewer punctures and shorter surgical time reported for sacral neuromodulation with 3D printing and ultrasound localization. (HealthDay News) — For patients with neurogenic bladder and pelvic ...
ascopubs.org

Contrast-enhanced intra-operative ultrasound as a clinical decision making tool during surgery for colorectal liver metastases: The ULIIS study.

Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs). Safety and tolerability of 5-FU, irinotecan (IRI), and nab-paclitaxel (FOLFIRABRAX) with genotype-guided ...
EurekAlert!

Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast cancer

NB: This will be the subject of an embargoed virtual news briefing Dr Antonio Esgueva at 14.00 hrs CET on Tuesday 15 November. Barcelona, Spain: Using ultrasound to guide surgery for patients with ...
ascopubs.org

Comparative analysis of CT-scan and PET-scan with intraoperative ultrasound (IOUS) in detecting liver metastases

QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study ...